BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.384,70 PKT +20,72 PKT +1,52 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
25.07.17 ABB (Asea Brown Boveri) Neutral Goldman Sachs Group Inc.
25.07.17 Givaudan Sell Société Générale Group S.A. (SG)
25.07.17 Swiss Re buy Deutsche Bank AG
25.07.17 UBS buy HSBC
24.07.17 ABB (Asea Brown Boveri) Sell UBS AG
24.07.17 Givaudan Neutral UBS AG
24.07.17 Novartis buy Jefferies & Company Inc.
21.07.17 Givaudan buy Baader Bank
21.07.17 Givaudan Neutral BNP PARIBAS
21.07.17 Zurich Insurance Neutral JP Morgan Chase & Co.
21.07.17 Givaudan overweight JP Morgan Chase & Co.
21.07.17 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
21.07.17 ABB (Asea Brown Boveri) Equal-Weight Morgan Stanley
21.07.17 Swiss Re overweight Morgan Stanley
21.07.17 ABB (Asea Brown Boveri) Hold Kepler Cheuvreux
21.07.17 Givaudan Neutral Goldman Sachs Group Inc.
21.07.17 ABB (Asea Brown Boveri) Hold Deutsche Bank AG
21.07.17 Givaudan Hold Deutsche Bank AG
21.07.17 Givaudan verkaufen Bernstein Research
20.07.17 Roche overweight JP Morgan Chase & Co.
20.07.17 UBS buy Deutsche Bank AG
20.07.17 UBS Hold Deutsche Bank AG
20.07.17 Holcim Hold Deutsche Bank AG
20.07.17 ABB (Asea Brown Boveri) Hold S&P Capital IQ
20.07.17 Novartis Neutral UBS AG
20.07.17 Roche Conviction Buy List Goldman Sachs Group Inc.
19.07.17 Novartis Neutral Goldman Sachs Group Inc.
19.07.17 UBS buy UBS AG
19.07.17 Novartis Outperform Bernstein Research
19.07.17 Novartis buy Société Générale Group S.A. (SG)
19.07.17 Novartis Neutral JP Morgan Chase & Co.
19.07.17 Holcim Hold Deutsche Bank AG
19.07.17 Novartis Hold Deutsche Bank AG
18.07.17 Novartis Outperform Bernstein Research
18.07.17 Roche Outperform Bernstein Research
18.07.17 Nestlé overweight JP Morgan Chase & Co.
18.07.17 UBS overweight Morgan Stanley
18.07.17 UBS overweight Morgan Stanley
18.07.17 Novartis Hold S&P Capital IQ
18.07.17 Novartis Neutral UBS AG